Zymeworks Says China's Health Regulator Accepts Biologics License Application for Cancer Therapy
Zymeworks Says China's Health Regulator Accepts Biologics License Application for Cancer Therapy
Zymeworks表示中國的健康監管機構已經接受了生物製品治療癌症的許可申請。
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊